TUVAS F Tablets – A powerful and comprehensive solution for high-risk patients.
TUVAS F Tablets – Rosuvastatin 10 mg + Fenofibrate 160 mg tablets, this combination tablet includes Rosuvastatin, a potent statin used to lower cholesterol levels, and Fenofibrate, a fibrate that primarily targets high triglyceride levels. Rosuvastatin reduces low-density lipoprotein (LDL) cholesterol (the “bad” cholesterol), increases high-density lipoprotein (HDL) cholesterol (the “good” cholesterol), and slows the progression of atherosclerosis. Fenofibrate helps lower triglyceride levels and can modestly increase HDL cholesterol. The combination of these two medications provides a comprehensive approach to managing dyslipidemia, particularly in patients with both high LDL cholesterol and elevated triglycerides
Recommended by Specialists
✅Cardiologists : For patients with mixed dyslipidemia and as part of comprehensive management for Atherosclerosis.
Key benefits of Rosuvastatin 10 mg+ Fenofibrate 160 mg tablets – TUVAS F Tablets
✅Dual Lipid Control: The combination addresses both high LDL cholesterol and elevated triglycerides, making it more effective for patients with mixed dyslipidemia compared to using either drug alone.
✅Enhanced Cardiovascular Risk Reduction: By targeting both cholesterol and triglycerides, this combination provides more comprehensive cardiovascular protection, particularly for patients at high risk of heart disease or stroke.
✅Synergistic Action: Rosuvastatin and Fenofibrate have complementary mechanisms of action—Rosuvastatin primarily reduces LDL, while Fenofibrate significantly lowers triglycerides—offering a broader lipid-lowering effect.
✅ Improved HDL levels
✅Convenient single pill therapy
Indications
✅Mixed dyslipidemia
✅Primary hypercholesterolemia with elevated triglycerides
✅Hypertriglyceridemia
✅ Atherosclerosis